Functional polymorphisms in the promoter regions of MMP2 and MMP3 are not associated with melanoma progression
2007

MMP2 and MMP3 Polymorphisms and Melanoma Progression

Sample size: 1002 publication Evidence: low

Author Information

Author(s): Cotignola Javier, Roy Pampa, Patel Ami, Ishill Nicole, Shah Shivang, Houghton Alan, Coit Daniel, Halpern Allan, Busam Klaus, Berwick Marianne, Orlow Irene

Primary Institution: Memorial Sloan-Kettering Cancer Center

Hypothesis

Do functional polymorphisms in MMP2 and MMP3 genes affect melanoma progression?

Conclusion

The study found no significant evidence linking MMP2 and MMP3 genetic variants to melanoma progression.

Supporting Evidence

  • No significant associations were found after adjusting for known melanoma confounders.
  • A new G to A variation in the MMP2 promoter was identified but its functional consequence is unclear.
  • The study included a diverse cohort of melanoma patients with various stages of the disease.

Takeaway

The researchers looked at specific genes to see if they affect melanoma, but they didn't find any strong links.

Methodology

The study evaluated MMP2 and MMP3 germline polymorphisms in melanoma patients using PCR-based methods and various statistical tests.

Limitations

The associations lost significance after adjusting for confounders like age, sex, and race.

Participant Demographics

95% were cutaneous malignant melanoma patients, predominantly Caucasian (96%), with ages ranging from 5 to 89 years.

Digital Object Identifier (DOI)

10.1186/1477-5751-6-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication